MAPT and tauopathy: The present study demonstrates that nearly complete inhibition of OGA via chronic treatment with Thiamet G reduces both pathological tau in the brain and total tau in the CSF of rTg4510 mice, thereby providing additional evidence that OGA inhibition may represent a safe and effective treatment for Alzheimer’s disease and other neurodegenerative diseases characterized by tauopathy.